Browsing by Author "Cedres Perez, Susana"
Now showing items 1-7 of 7
-
A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer
Yamamoto, Nobuyuki; Hayashi, Hidetoshi; Planchard, David; Morán, Teresa; Gregorc, Vanesa; Dowell, Jonathan; Cedres Perez, Susana (Springer, 2020-10) -
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
Cedres Perez, Susana; Assaf, Juan David; Iranzo Gómez, Patricia; Callejo Perez, Ana; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Marmolejo, David; Rezqallah Aron, Maria Alejandra; Carbonell, Caterina; Frigola Rissech, Joan; Amat, Ramon; Pedrola Gómez, Anna; Dienstmann, Rodrigo; Felip Font, Enriqueta (Nature Research, 2021-11-01) -
Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
Callejo Perez, Ana; Frigola Rissech, Joan; Iranzo Gómez, Patricia; Carbonell, Caterina; Diaz-Mejia, Nely; Marmolejo, David; Assaf, Juan David; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Pardo Aranda, Nuria; Amat, Ramon; Felip Font, Enriqueta (MDPI, 2021-07) -
Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient
Domingues, I.; Cedres Perez, Susana; Callejo Perez, Ana; Vivancos Prellezo, Ana; Martínez Marti, Alexandre; Felip Font, Enriqueta (Elsevier, 2020-01) -
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Frigola Rissech, Joan; Navarro Mendivil, Alejandro; Carbonell, Caterina; Callejo Perez, Ana; Iranzo Gómez, Patricia; Cedres Perez, Susana; Martínez Marti, Alexandre; Pardo Aranda, Nuria; Saoudi Gonzalez, Nadia; Jiménez Flores, José Antonio; Sansano Valero, Irene; Mancuso, Francesco Mattia; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Felip Font, Enriqueta; Amat, Ramon (Wiley, 2021-04) -
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
Haakensen, Vilde Drageset; Nowak, Anna K.; Ellingsen, Espen Basmo; Farooqi, Saima Jamil; Bjaanæs, Maria Moksnes; Horndalsveen, Henrik; Cedres Perez, Susana (BMC, 2021-05-31) -
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)
Nadal, Ernest; Bosch-Barrera, J; Cedres Perez, Susana; Coves, J.; García‑Campelo, R.; Guirado, M. (Springer, 2021-05)